An Augmented Modulated Deep Learning Based Intelligent Predictive Model for Brain Tumor Detection Using GAN Ensemble.
PGGAN
brain tumor
deep learning
generative adversarial network
machine learning
soft voting
Journal
Sensors (Basel, Switzerland)
ISSN: 1424-8220
Titre abrégé: Sensors (Basel)
Pays: Switzerland
ID NLM: 101204366
Informations de publication
Date de publication:
03 Aug 2023
03 Aug 2023
Historique:
received:
26
05
2023
revised:
25
07
2023
accepted:
28
07
2023
medline:
14
8
2023
pubmed:
12
8
2023
entrez:
12
8
2023
Statut:
epublish
Résumé
Brain tumor detection in the initial stage is becoming an intricate task for clinicians worldwide. The diagnosis of brain tumor patients is rigorous in the later stages, which is a serious concern. Although there are related pragmatic clinical tools and multiple models based on machine learning (ML) for the effective diagnosis of patients, these models still provide less accuracy and take immense time for patient screening during the diagnosis process. Hence, there is still a need to develop a more precise model for more accurate screening of patients to detect brain tumors in the beginning stages and aid clinicians in diagnosis, making the brain tumor assessment more reliable. In this research, a performance analysis of the impact of different generative adversarial networks (GAN) on the early detection of brain tumors is presented. Based on it, a novel hybrid enhanced predictive convolution neural network (CNN) model using a hybrid GAN ensemble is proposed. Brain tumor image data is augmented using a GAN ensemble, which is fed for classification using a hybrid modulated CNN technique. The outcome is generated through a soft voting approach where the final prediction is based on the GAN, which computes the highest value for different performance metrics. This analysis demonstrated that evaluation with a progressive-growing generative adversarial network (PGGAN) architecture produced the best result. In the analysis, PGGAN outperformed others, computing the accuracy, precision, recall, F1-score, and negative predictive value (NPV) to be 98.85, 98.45%, 97.2%, 98.11%, and 98.09%, respectively. Additionally, a very low latency of 3.4 s is determined with PGGAN. The PGGAN model enhanced the overall performance of the identification of brain cell tissues in real time. Therefore, it may be inferred to suggest that brain tumor detection in patients using PGGAN augmentation with the proposed modulated CNN technique generates the optimum performance using the soft voting approach.
Identifiants
pubmed: 37571713
pii: s23156930
doi: 10.3390/s23156930
pmc: PMC10422344
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Multimed Tools Appl. 2023 Apr 25;:1-31
pubmed: 37362641
Sensors (Basel). 2022 Jan 04;22(1):
pubmed: 35009911
Front Comput Neurosci. 2022 Sep 02;16:1005617
pubmed: 36118133
Tomography. 2020 Jun;6(2):186-193
pubmed: 32548295
Comput Methods Programs Biomed. 2021 Mar;200:105797
pubmed: 33317871
Comput Math Methods Med. 2022 Jul 1;2022:2858845
pubmed: 35813426
Sensors (Basel). 2021 Mar 22;21(6):
pubmed: 33810176
Front Oncol. 2021 Jun 04;11:690244
pubmed: 34150660
Comput Math Methods Med. 2022 May 18;2022:8330833
pubmed: 35633922
J Imaging. 2022 Jul 22;8(8):
pubmed: 35893083
BMC Med Inform Decis Mak. 2023 Jan 23;23(1):16
pubmed: 36691030
Sci Rep. 2022 Sep 12;12(1):15331
pubmed: 36097024